RTW Biotech Opportunities Ltd Share Price

Equities

RTWG

GG00BKTRRM22

Closed End Funds

Market Closed - London S.E. 16:35:16 26/04/2024 BST 5-day change 1st Jan Change
1.31 USD -1.13% Intraday chart for RTW Biotech Opportunities Ltd +1.16% -6.60%
Sales 2021 0.66 52.59 Sales 2022 2.17 173.31 Capitalization 257M 20.55B
Net income 2021 -64M -5.12B Net income 2022 -39M -3.12B EV / Sales 2021 564,951,510 x
Net cash position 2021 6.48M 519M Net cash position 2022 6.97M 557M EV / Sales 2022 115,364,471 x
P/E ratio 2021
-5.88 x
P/E ratio 2022
-6.52 x
Employees -
Yield 2021 *
-
Yield 2022
-
Free-Float 87.76%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.13%
1 week+1.16%
Current month-0.76%
1 month-0.76%
3 months-5.24%
6 months+14.41%
Current year-6.60%
More quotes
1 week
1.28
Extreme 1.28
1.33
1 month
1.28
Extreme 1.28
1.35
Current year
1.26
Extreme 1.255
1.43
1 year
1.05
Extreme 1.05
1.43
3 years
0.93
Extreme 0.932
2.26
5 years
0.93
Extreme 0.932
2.50
10 years
0.93
Extreme 0.932
2.50
More quotes
Members of the board TitleAgeSince
Chairman 68 -
Director/Board Member - 29/10/19
Director/Board Member 64 29/10/19
More insiders
Date Price Change Volume
26/04/24 1.31 -1.13% 237,817
25/04/24 1.325 +1.15% 726,443
24/04/24 1.31 -1.13% 414,876
23/04/24 1.325 +1.53% 658,467
22/04/24 1.305 +0.77% 370,157

Delayed Quote London S.E., April 26, 2024 at 04:35 pm

More quotes
RTW Biotech Opportunities Ltd is a Guernsey-based focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. The Company invests in companies developing therapies and technologies that can significantly improve patients' lives. The Company seeks to achieve its investment objective by leveraging the Investment Manager's data driven pipeline of assets to invest in life sciences companies across various therapeutic categories and product types (including genetic medicines, biologics, traditional modalities, such as small molecule pharmaceuticals and antibodies, and medical devices). It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life. The Company's portfolio is managed by RTW Investments, LP.
Calendar
More about the company